Search

John A. Ward

Examiner (ID: 10393)

Most Active Art Unit
2875
Art Unit(s)
2885, 2875
Total Applications
1293
Issued Applications
1015
Pending Applications
41
Abandoned Applications
239

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4797102 [patent_doc_number] => 20080008688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'System and Method for Genetically Treating Cardiac Conduction Disturbances' [patent_app_type] => utility [patent_app_number] => 11/421301 [patent_app_country] => US [patent_app_date] => 2006-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9664 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 61 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20080008688.pdf [firstpage_image] =>[orig_patent_app_number] => 11421301 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/421301
System and method for genetically treating cardiac conduction disturbances May 30, 2006 Issued
Array ( [id] => 5492067 [patent_doc_number] => 20090293138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'ANIMAL MODELS CARRYING TUMORS EXPRESSING HUMAN PROSTATE CANCER-SPECIFIC ANTIGEN AND METHOD FOR ANALYZING PREVENTION AND TREATMENT EFFICACY OF DENDRITIC CELLS-DERIVED IMMUNOTHERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 11/915737 [patent_app_country] => US [patent_app_date] => 2006-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8615 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20090293138.pdf [firstpage_image] =>[orig_patent_app_number] => 11915737 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/915737
ANIMAL MODELS CARRYING TUMORS EXPRESSING HUMAN PROSTATE CANCER-SPECIFIC ANTIGEN AND METHOD FOR ANALYZING PREVENTION AND TREATMENT EFFICACY OF DENDRITIC CELLS-DERIVED IMMUNOTHERAPEUTICS May 26, 2006 Abandoned
Array ( [id] => 5687759 [patent_doc_number] => 20060286074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Methods for immunotherapy of cancer' [patent_app_type] => utility [patent_app_number] => 11/441822 [patent_app_country] => US [patent_app_date] => 2006-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 22289 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20060286074.pdf [firstpage_image] =>[orig_patent_app_number] => 11441822 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/441822
Methods for immunotherapy of cancer May 25, 2006 Abandoned
Array ( [id] => 4495055 [patent_doc_number] => 07956238 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-07 [patent_title] => 'Porcine pancreatic amylase gene promoter and transgenic pigs expressing heterologous digestive enzymes' [patent_app_type] => utility [patent_app_number] => 11/438979 [patent_app_country] => US [patent_app_date] => 2006-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5801 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/956/07956238.pdf [firstpage_image] =>[orig_patent_app_number] => 11438979 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/438979
Porcine pancreatic amylase gene promoter and transgenic pigs expressing heterologous digestive enzymes May 22, 2006 Issued
Array ( [id] => 5367091 [patent_doc_number] => 20090304650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Repair of the Bone Marrow Vasculature' [patent_app_type] => utility [patent_app_number] => 11/914007 [patent_app_country] => US [patent_app_date] => 2006-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 18335 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304650.pdf [firstpage_image] =>[orig_patent_app_number] => 11914007 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/914007
Repair of the Bone Marrow Vasculature May 10, 2006 Abandoned
Array ( [id] => 5705200 [patent_doc_number] => 20060194248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Method of measuring human CYP3A inducibility' [patent_app_type] => utility [patent_app_number] => 11/414189 [patent_app_country] => US [patent_app_date] => 2006-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4544 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194248.pdf [firstpage_image] =>[orig_patent_app_number] => 11414189 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/414189
Method of measuring human CYP3A inducibility Apr 30, 2006 Abandoned
Array ( [id] => 5292365 [patent_doc_number] => 20090025095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Method for Evaluating Compound Using Barlp and Substance for Regulating Eating and Body Weight' [patent_app_type] => utility [patent_app_number] => 11/918099 [patent_app_country] => US [patent_app_date] => 2006-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6911 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20090025095.pdf [firstpage_image] =>[orig_patent_app_number] => 11918099 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/918099
Method for Evaluating Compound Using Barlp and Substance for Regulating Eating and Body Weight Apr 24, 2006 Abandoned
Array ( [id] => 292221 [patent_doc_number] => 07544510 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-09 [patent_title] => 'Stem cells of the islets of Langerhans and their use in treating diabetes mellitus' [patent_app_type] => utility [patent_app_number] => 11/410412 [patent_app_country] => US [patent_app_date] => 2006-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 17 [patent_no_of_words] => 18327 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/544/07544510.pdf [firstpage_image] =>[orig_patent_app_number] => 11410412 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/410412
Stem cells of the islets of Langerhans and their use in treating diabetes mellitus Apr 23, 2006 Issued
Array ( [id] => 5016134 [patent_doc_number] => 20070259343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Somatic transfer of modified genes to predict drug effects' [patent_app_type] => utility [patent_app_number] => 11/397346 [patent_app_country] => US [patent_app_date] => 2006-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 13742 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259343.pdf [firstpage_image] =>[orig_patent_app_number] => 11397346 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/397346
Somatic transfer of modified genes to predict drug effects Apr 2, 2006 Abandoned
Array ( [id] => 5753484 [patent_doc_number] => 20060222633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Prevention, decrease, and/or treatment of immunoreactivity by depleting and/or inactivating antigen presenting cells in the host' [patent_app_type] => utility [patent_app_number] => 11/377647 [patent_app_country] => US [patent_app_date] => 2006-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 26945 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20060222633.pdf [firstpage_image] =>[orig_patent_app_number] => 11377647 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/377647
Prevention, decrease, and/or treatment of immunoreactivity by depleting and/or inactivating antigen presenting cells in the host Mar 16, 2006 Abandoned
Array ( [id] => 5887551 [patent_doc_number] => 20060275270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'In vitro mucosal tissue equivalent' [patent_app_type] => utility [patent_app_number] => 11/375128 [patent_app_country] => US [patent_app_date] => 2006-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 14339 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275270.pdf [firstpage_image] =>[orig_patent_app_number] => 11375128 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/375128
In vitro mucosal tissue equivalent Mar 14, 2006 Abandoned
Array ( [id] => 6254316 [patent_doc_number] => 20100138936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'Transgenic Mice and Use Thereof as an Experimental Model' [patent_app_type] => utility [patent_app_number] => 11/885429 [patent_app_country] => US [patent_app_date] => 2006-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 4128 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20100138936.pdf [firstpage_image] =>[orig_patent_app_number] => 11885429 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/885429
Transgenic Mice and Use Thereof as an Experimental Model Mar 5, 2006 Abandoned
Array ( [id] => 5984586 [patent_doc_number] => 20110097330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'Novel Gene Disruptions, Compostitions and Methods Relating Thereto' [patent_app_type] => utility [patent_app_number] => 11/722967 [patent_app_country] => US [patent_app_date] => 2006-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 161 [patent_figures_cnt] => 161 [patent_no_of_words] => 285847 [patent_no_of_claims] => 141 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20110097330.pdf [firstpage_image] =>[orig_patent_app_number] => 11722967 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/722967
Novel Gene Disruptions, Compostitions and Methods Relating Thereto Feb 26, 2006 Abandoned
Array ( [id] => 5517087 [patent_doc_number] => 20090217394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Diabetes Model Animal' [patent_app_type] => utility [patent_app_number] => 11/884943 [patent_app_country] => US [patent_app_date] => 2006-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10246 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20090217394.pdf [firstpage_image] =>[orig_patent_app_number] => 11884943 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/884943
Diabetes Model Animal Feb 26, 2006 Abandoned
Array ( [id] => 5336813 [patent_doc_number] => 20090053277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Cell Sheet Containing Mesenchymal Stem Cells' [patent_app_type] => utility [patent_app_number] => 11/883243 [patent_app_country] => US [patent_app_date] => 2006-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6391 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053277.pdf [firstpage_image] =>[orig_patent_app_number] => 11883243 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/883243
Cell sheet containing mesenchymal stem cells Jan 26, 2006 Issued
Array ( [id] => 5289969 [patent_doc_number] => 20090022699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Method Of Genotypically Modifying Cells By Administration Of RNA' [patent_app_type] => utility [patent_app_number] => 11/814271 [patent_app_country] => US [patent_app_date] => 2006-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 36904 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11814271 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/814271
Method Of Genotypically Modifying Cells By Administration Of RNA Jan 18, 2006 Abandoned
Array ( [id] => 4813400 [patent_doc_number] => 20080194031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Alterations Utilizing Nanoparticles' [patent_app_type] => utility [patent_app_number] => 11/795292 [patent_app_country] => US [patent_app_date] => 2006-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 6652 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194031.pdf [firstpage_image] =>[orig_patent_app_number] => 11795292 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/795292
Alterations utilizing nanoparticles Jan 17, 2006 Issued
Array ( [id] => 452787 [patent_doc_number] => 07247475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-24 [patent_title] => 'Method for producing monoclonal antibodies' [patent_app_type] => utility [patent_app_number] => 11/324255 [patent_app_country] => US [patent_app_date] => 2006-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4368 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/247/07247475.pdf [firstpage_image] =>[orig_patent_app_number] => 11324255 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/324255
Method for producing monoclonal antibodies Jan 3, 2006 Issued
Array ( [id] => 83673 [patent_doc_number] => 07741300 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Methods of using nucleic acid vector-lipid complexes' [patent_app_type] => utility [patent_app_number] => 11/320019 [patent_app_country] => US [patent_app_date] => 2005-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 33 [patent_no_of_words] => 20038 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741300.pdf [firstpage_image] =>[orig_patent_app_number] => 11320019 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/320019
Methods of using nucleic acid vector-lipid complexes Dec 26, 2005 Issued
Array ( [id] => 7523068 [patent_doc_number] => 08026224 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-27 [patent_title] => 'Tumor cells with increased immunogenicity and uses therfor' [patent_app_type] => utility [patent_app_number] => 11/313556 [patent_app_country] => US [patent_app_date] => 2005-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 8 [patent_no_of_words] => 14978 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/026/08026224.pdf [firstpage_image] =>[orig_patent_app_number] => 11313556 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/313556
Tumor cells with increased immunogenicity and uses therfor Dec 19, 2005 Issued
Menu